Please wait a moment until all data is loaded. This message will disappear when all data is loaded.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
4-bromophenol + NADH + H+ + O2
4-bromocatechol + NAD+ + H2O
rate of halophenol consumption 2.9 microM/min/g cell dry weight
-
-
?
4-chlorophenol + NADH + H+ + O2
4-chlorocatechol + NAD+ + H2O
rate of halophenol consumption 3.3 microM/min/g cell dry weight
-
-
?
4-fluorophenol + NADH + H+ + O2
4-fluorocatechol + NAD+ + H2O
rate of halophenol consumption 5.3 microM/min/g cell dry weight
-
-
?
4-iodophenol + NADH + H+ + O2
4-iodocatechol + NAD+ + H2O
rate of halophenol consumption 1.7 microM/min/g cell dry weight
-
-
?
(3,4-dihydroxyphenyl)acetate + NADH + H+ + O2
? + NAD+ + H2O
-
-
-
-
?
2,5-dihydroxyphenylacetate + ?
?
-
155% of 4-hydroxyphenylacetate activity
-
-
?
2-(4-hydroxyphenyl)ethanol + NADH + H+ + O2
? + NAD+ + H2O
-
-
-
-
?
3,4-dihydroxyphenylacetate + ?
?
-
65% of 4-hydroxyphenylacetate
-
-
?
3-hydroxyphenylacetate + FMNH2 + O2
3,4-hydroxyphenylacetate + FMN + H2O
-
-
-
-
?
3-hydroxyphenylacetate + NADH + H+ + O2
3,4-hydroxyphenylacetate + NAD+ + H2O
-
-
-
-
?
3-hydroxyphenylacetate + NADH + O2
3,4-hydroxyphenylacetate + NAD+ + H2O
-
82% activity of 4-hydroxyphenylacetate
-
?
4-coumarate + NADH + H+ + O2
? + NAD+ + H2O
-
-
-
-
?
4-coumaric acid + FADH2 + O2
caffeic acid + FAD + H2O
4-hydroxyphenylacetate + FADH2 + O2
3,4-dihydroxyphenylacetate + FAD + H2O
-
-
-
-
?
4-hydroxyphenylacetate + NADH + O2
3,4-dihydroxyphenylacetate + NAD+ + H2O
DL-4-hydroxymandelic acid + NADH + H+ + O2
? + NAD+ + H2O
-
-
-
-
?
L-tyrosine + FADH2 + O2
L-(3,4-dihydroxy)phenylalanine + FAD + H2O
-
-
-
-
?
methyl 4-hydroxybenzoate + NADH + H+ + O2
? + NAD+ + H2O
-
-
-
-
?
naringenin + FADH2 + O2
? + FAD + H2O
-
-
-
?
naringin + NADH + H+ + O2
eryodictyol + NADP+ + H2O
-
-
-
?
p-cresol + ?
?
-
51% of 4-hydroxyphenylacetate activity
-
-
?
phenol + NADH + H+ + O2
? + NAD+ + H2O
-
-
-
-
?
resveratrol + FADH2 + O2
? + FAD + H2O
-
-
-
?
riboflavin + NADH + H+
reduced riboflavin + NAD+
-
-
-
-
r
umbelliferone + FADH2 + O2
? + FAD + H2O
-
-
-
?
additional information
?
-
4-coumaric acid + FADH2 + O2
caffeic acid + FAD + H2O
-
-
-
-
?
4-coumaric acid + FADH2 + O2
caffeic acid + FAD + H2O
-
-
-
?
4-hydroxyphenylacetate + NADH + O2
3,4-dihydroxyphenylacetate + NAD+ + H2O
-
-
-
?
4-hydroxyphenylacetate + NADH + O2
3,4-dihydroxyphenylacetate + NAD+ + H2O
-
-
-
?
4-hydroxyphenylacetate + NADH + O2
3,4-dihydroxyphenylacetate + NAD+ + H2O
-
-
-
?
4-hydroxyphenylacetate + NADH + O2
3,4-dihydroxyphenylacetate + NAD+ + H2O
-
-
-
?
4-hydroxyphenylacetate + NADH + O2
3,4-dihydroxyphenylacetate + NAD+ + H2O
-
-
-
-
?
4-hydroxyphenylacetate + NADH + O2
3,4-dihydroxyphenylacetate + NAD+ + H2O
-
O2 can be replaced by FADH
-
?
4-hydroxyphenylacetate + NADH + O2
3,4-dihydroxyphenylacetate + NAD+ + H2O
-
enzyme is induced by 4-hydroxyphenylacetate, no constitutive synthesis
-
ir
4-hydroxyphenylacetate + NADH + O2
3,4-dihydroxyphenylacetate + NAD+ + H2O
-
initial reaction in the degradation of 4-hydroxyphenylacetate
-
?
4-hydroxyphenylacetate + NADH + O2
3,4-dihydroxyphenylacetate + NAD+ + H2O
-
inducible chromosomally encoded meta-cleavage pathway of aromatic degradation
-
?
4-hydroxyphenylacetate + NADH + O2
3,4-dihydroxyphenylacetate + NAD+ + H2O
-
degradation of 4-hydroxyphenylacetate by inducible meta-cleavage pathway
-
?
4-hydroxyphenylacetate + NADH + O2
3,4-dihydroxyphenylacetate + NAD+ + H2O
-
4-hydroxyphenylacetic acid degradative pathway
-
?
4-hydroxyphenylacetate + NADH + O2
3,4-dihydroxyphenylacetate + NAD+ + H2O
-
first enzyme in 4-hydroxyphenylacetate metabolism
-
-
?
phenol + ?
catechol + ?
-
-
-
?
phenol + ?
catechol + ?
-
for HpaB
-
?
additional information
?
-
-
-
-
-
?
additional information
?
-
-
hydroxylates phenol derivatives
-
-
?
additional information
?
-
-
rather broad substrate specificity, acting on mono- and dihydric phenols. Several substrates are below 50% of activity
-
-
?
additional information
?
-
-
3- and 4-hydroxyphenylacetate are both catalyzed by 3- or 4-hydroxyphenylacetate hydroxylase by the same route with 3,4-dihydroxyphenylacetate as the first common intermediate, cells grown on one compound are fully induced for the catabolism of the other
-
-
?
additional information
?
-
-
hydroxylation of aromatic compounds
-
-
?
additional information
?
-
-
the enzyme does not form stable complexes or channel substrates with the NAD(P)H-flavin oxidoredctase HpaC, but NAD(P)H-flavin oxidoreductase HpaC is required for delivering of sufficient amounts of FADH2
-
-
?
additional information
?
-
-
no substrates: benzoic acid, dihydroxybenzoic acid, 4-methoxyphenylacetic acid, catechol, 4-hydroxy-D-2-phenylglycine, 4-hydroxy-L-2-phenylglycine, 3-hydroxy-4-methoxyphenylacetic acid, 4-tert-butylphenol, 3-methoxyphenylacetic acid, 4-hydroxy-3-methoxyphenylacetic acid
-
-
-
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
4-hydroxyphenylacetate + FADH2 + O2
3,4-dihydroxyphenylacetate + FAD + H2O
-
-
-
-
?
4-hydroxyphenylacetate + NADH + O2
3,4-dihydroxyphenylacetate + NAD+ + H2O
additional information
?
-
-
the enzyme does not form stable complexes or channel substrates with the NAD(P)H-flavin oxidoredctase HpaC, but NAD(P)H-flavin oxidoreductase HpaC is required for delivering of sufficient amounts of FADH2
-
-
?
4-hydroxyphenylacetate + NADH + O2
3,4-dihydroxyphenylacetate + NAD+ + H2O
-
-
-
?
4-hydroxyphenylacetate + NADH + O2
3,4-dihydroxyphenylacetate + NAD+ + H2O
-
initial reaction in the degradation of 4-hydroxyphenylacetate
-
?
4-hydroxyphenylacetate + NADH + O2
3,4-dihydroxyphenylacetate + NAD+ + H2O
-
inducible chromosomally encoded meta-cleavage pathway of aromatic degradation
-
?
4-hydroxyphenylacetate + NADH + O2
3,4-dihydroxyphenylacetate + NAD+ + H2O
-
degradation of 4-hydroxyphenylacetate by inducible meta-cleavage pathway
-
?
4-hydroxyphenylacetate + NADH + O2
3,4-dihydroxyphenylacetate + NAD+ + H2O
-
4-hydroxyphenylacetic acid degradative pathway
-
?
4-hydroxyphenylacetate + NADH + O2
3,4-dihydroxyphenylacetate + NAD+ + H2O
-
first enzyme in 4-hydroxyphenylacetate metabolism
-
-
?
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
H155A
-
drastically decreased hydroxylase activity with substrate 3-hydroxyphenylacetate
I157A
-
complete loss of hydroxylase activity
I157G
-
complete loss of hydroxylase activity
I157S
-
complete loss of hydroxylase activity
R113A
-
drastically decreased hydroxylase activity with substrate 3-hydroxyphenylacetate
R379G
contrary to wild-type, mutant is not able to grow on 3-hydroxyphenylacetic acid. Residue 379 is located in the vicinity of the 4-hydroxyphenylacetic acid binding site, and plays an important role in mediating the entrance and stable binding of substrates to the active site
R379S
contrary to wild-type, mutant is not able to grow on 3-hydroxyphenylacetic acid
S210A
-
drastically decreased hydroxylase activity
S210Q
-
drastically decreased hydroxylase activity
synthesis
construction of biosynthetic pathways for the production of tyrosol acetate and hydroxytyrosol acetate in Escherichia coli. Escherichia coli YeaE is the best aldehyde reductase for tyrosol accumulation. Tyrosol acetate production is achieved by overexpression of alcohol acetyltransferase ATF1 from Saccharomyces cerevisiae, and hydroxytyrosol acetate production by overexpression of 4-hydroxyphenylacetate 3-hydroxylase genes HpaBC
V158G
-
complete loss of hydroxylase activity
Y117A
-
drastically decreased hydroxylase activity with substrate 3-hydroxyphenylacetate
additional information
-
W21, 4-hydroxyphenylacetate deficient mutant
additional information
-
creation of 4-hydroxyphenylacetate-negative mutants by minimal salt medium with ethylmethanesulfonate
additional information
changing the amino acid residues of section I of the flexible loop (mutant XS2, amino acids 207-211, GlyPheGlySerAla) into larger ones does not change the original secondary structure and the flexibility of the loop. The mutants show decreased activity towards substrates 4-coumaric acid, umbelliferone, resveratrol and naringenin. Changing the amino acid residues of section III of the flexible loop (mutant XS3, amino acids 215-217, GlyGluAsn) increases the Km values of towards p-coumaric acid and umbelliferone by 1.7fold and 1.2fold, respectively. The kcat value towards umbelliferone decreases by almost 2fold. Mutant XS4 incorporating the mutations in both XS2 and XS3 still keeps the secondary structure of the loop unchanged unchanged. In mutant XS5 the secondary structure of the loop is changed by replacing residues in section II of the loop (GlnValMet) with GlySerGly. Mutant XS5 shows reduced catalytic activity towards p-coumaric acid, umbelliferone and resveratrol. Mutant XS6 employs a loop containing mainly Gly, Ser, and Asp residues and shows the almost same specificity constant values towards p-coumaric acid and umbelliferone as wild-type
additional information
-
changing the amino acid residues of section I of the flexible loop (mutant XS2, amino acids 207-211, GlyPheGlySerAla) into larger ones does not change the original secondary structure and the flexibility of the loop. The mutants show decreased activity towards substrates 4-coumaric acid, umbelliferone, resveratrol and naringenin. Changing the amino acid residues of section III of the flexible loop (mutant XS3, amino acids 215-217, GlyGluAsn) increases the Km values of towards p-coumaric acid and umbelliferone by 1.7fold and 1.2fold, respectively. The kcat value towards umbelliferone decreases by almost 2fold. Mutant XS4 incorporating the mutations in both XS2 and XS3 still keeps the secondary structure of the loop unchanged unchanged. In mutant XS5 the secondary structure of the loop is changed by replacing residues in section II of the loop (GlnValMet) with GlySerGly. Mutant XS5 shows reduced catalytic activity towards p-coumaric acid, umbelliferone and resveratrol. Mutant XS6 employs a loop containing mainly Gly, Ser, and Asp residues and shows the almost same specificity constant values towards p-coumaric acid and umbelliferone as wild-type
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Cooper, R.A.; Skinner, M.A.
Catabolism of 3- and 4-hydroxyphenylacetate by the 3,4-dihydroxyphenylacetate pathway in Escherichia coli
J. Bacteriol.
143
302-306
1980
Escherichia coli, Escherichia coli C
brenda
Prieto, M.A.; Garcia, J.L.
Molecular characterization of 4-hydroxyphenylacetate 3-hydroxylase of Escherichia coli. A two-protein component enzyme
J. Biol. Chem.
269
22823-22829
1994
Escherichia coli, no activity in Escherichia coli K-12
brenda
Prieto, M.A.; Perez-Aranda, A.; Garcia, J.L.
Characterization of an Escherichia coli aromatic hydroxylase with a broad substrate range
J. Bacteriol.
175
2162-2167
1993
Escherichia coli, no activity in Escherichia coli K-12
brenda
Xun, L.; Sandvik, E.R.
Characterization of 4-hydroxyphenylacetate 3-hydroxylase (HpaB) of Escherichia coli as a reduced flavin adenine dinucleotide-utilizing monooxygenase
Appl. Environ. Microbiol.
66
481-486
2000
Escherichia coli
brenda
Galan, B.; Diaz, E.; Prieto, M.A.; Garcia, J.L.
Functional analysis of the small component of the 4-hydroxyphenylacetate 3-monooxygenase of Escherichia coli W: a prototype of a new flavin:NAD(P)H reductase subfamily
J. Bacteriol.
182
627-636
2000
Escherichia coli, Klebsiella pneumoniae
brenda
Chaiyen, P.; Suadee, C.; Wilairat, P.
A novel two-protein component flavoprotein hydroxylase. p-Hydroxyphenylacetate hydroxylase from Acinetobacter baumannii
Eur. J. Biochem.
268
5550-5561
2001
Acinetobacter baumannii, Escherichia coli, Pseudomonas putida
brenda
Louie, T.M.; Xie, X.S.; Xun, L.
Coordinated production and utilization of FADH2 by NAD(P)H-flavin oxidoreductase and 4-hydroxyphenylacetate 3-monooxygenase
Biochemistry
42
7509-7517
2003
Escherichia coli
brenda
Coulombel, L.; Nolan, L.C.; Nikodinovic, J.; Doyle, E.M.; OConnor, K.E.
Biotransformation of 4-halophenols to 4-halocatechols using Escherichia coli expressing 4-hydroxyphenylacetate 3-hydroxylase
Appl. Microbiol. Biotechnol.
89
1867-1875
2011
Escherichia coli (Q57160), Escherichia coli
brenda
Huang, Q.; Lin, Y.; Yan, Y.
Caffeic acid production enhancement by engineering a phenylalanine over-producing Escherichia coli strain
Biotechnol. Bioeng.
110
3188-3196
2013
Escherichia coli, Escherichia coli ATCC 31884
brenda
Kim, H.; Kim, S.; Kim, D.; Yoon, S.H.
A single amino acid substitution in aromatic hydroxylase (HpaB) of Escherichia coli alters substrate specificity of the structural isomers of hydroxyphenylacetate
BMC Microbiol.
20
109
2020
Escherichia coli (A0A140NG21), Escherichia coli, Escherichia coli BL21-DE3 (A0A140NG21)
brenda
Deng, Y.; Faivre, B.; Back, O.; Lombard, M.; Pecqueur, L.; Fontecave, M.
Structural and functional characterization of 4-hydroxyphenylacetate 3-hydroxylase from Escherichia coli
ChemBioChem
21
163-170
2020
Escherichia coli
brenda
Guo, D.; Fu, X.; Sun, Y.; Li, X.; Pan, H.
De novo biosynthesis of tyrosol acetate and hydroxytyrosol acetate from glucose in engineered Escherichia coli
Enzyme Microb. Technol.
150
109886
2021
Escherichia coli (A0A140NG21), Escherichia coli, Escherichia coli BL21-DE3 (A0A140NG21)
brenda
Muniz-Calvo, S.; Bisquert, R.; Puig, S.; Guillamon, J.M.
Overproduction of hydroxytyrosol in Saccharomyces cerevisiae by heterologous overexpression of the Escherichia coli 4-hydroxyphenylacetate 3-monooxygenase
Food Chem.
308
125646
2020
Escherichia coli (A0A140NG21), Escherichia coli, Escherichia coli BL21-DE3 (A0A140NG21)
brenda
Wang, L.; Ma, X.; Ruan, H.; Chen, Y.; Gao, L.; Lei, T.; Li, Y.; Gui, L.; Guo, L.; Xia, T.; Wang, Y.
Optimization of the biosynthesis of B-ring ortho-hydroxylated flavonoids using the 4-hydroxyphenylacetate 3-hydroxylase complex (HpaBC) of Escherichia coli
Molecules
26
2919
2021
Escherichia coli (A0A140NG21), Escherichia coli, Escherichia coli BL21-DE3 (A0A140NG21)
brenda
Shen, X.; Zhou, D.; Lin, Y.; Wang, J.; Gao, S.; Kandavelu, P.; Zhang, H.; Zhang, R.; Wang, B.C.; Rose, J.; Yuan, Q.; Yan, Y.
Structural insights into catalytic versatility of the flavin-dependent hydroxylase (HpaB) from Escherichia coli
Sci. Rep.
9
7087
2019
Escherichia coli (A0A140NG21), Escherichia coli, Escherichia coli BL21-DE3 (A0A140NG21)
brenda